← Back to Screener
Mannatech Inc. (MTEX)
Price$5.70
Value ScoreB
Growth ScoreD
Momentum ScoreD
Favorite Metrics
Price vs S&P 500 (26W)-47.67%
Price vs S&P 500 (4W)0.01%
VGM Score42.72
Market Capitalization$11.00M
P/E Ratio (Annual)4.42x
Indicated Dividend Yield (Annual)8.83%
All Metrics
P/CF (Annual)4.86x
Book Value / Share (Quarterly)$3.66
P/TBV (Annual)3.01x
Indicated Dividend (Annual)$0.00
Revenue Growth (3Y)-7.66%
Cash Flow / Share (Quarterly)$-0.76
Price vs S&P 500 (YTD)-37.17%
Gross Margin (TTM)75.27%
Net Profit Margin (TTM)-11.97%
EPS (TTM)$-6.71
10-Day Avg Trading Volume0.01M
EPS Excl Extra (TTM)$-6.71
Revenue Growth (5Y)-6.53%
EPS (Annual)$-8.00
Dividend / Share (Annual)$0.00
ROI (Annual)19.84%
Gross Margin (Annual)74.94%
Net Profit Margin (5Y Avg)-2.16%
Cash / Share (Quarterly)$3.63
Revenue Growth QoQ (YoY)-6.20%
EPS Growth (5Y)-0.80%
P/E Normalized (Annual)4.42x
ROA (Last FY)-50.72%
Revenue Growth TTM (YoY)-7.51%
EBITD / Share (TTM)$0.67
ROE (5Y Avg)8.05%
Operating Margin (TTM)0.21%
Cash Flow / Share (Annual)$-2.27
P/B Ratio1.58x
P/B Ratio (Quarterly)2.72x
Net Income / Employee (Annual)$-89,500
EV / Revenue (TTM)0.07x
Net Interest Coverage (TTM)-0.15x
ROA (TTM)-40.24%
EV / EBITDA (TTM)6.00x
EPS Incl Extra (Annual)$-8.00
Current Ratio (Annual)1.10x
Quick Ratio (Quarterly)0.46x
3-Month Avg Trading Volume0.02M
52-Week Price Return-59.73%
EV / Free Cash Flow (Annual)3.82x
Revenue / Employee (TTM)$625,800
Tangible BV / Share (Quarterly)$4.46
P/S Ratio (Annual)0.10x
Asset Turnover (Annual)3.60x
52-Week High$12.45
Operating Margin (5Y Avg)1.09%
EPS Excl Extra (Annual)$-8.00
CapEx CAGR (5Y)7.33%
Tangible BV CAGR (5Y)-20.86%
26-Week Price Return-39.75%
Quick Ratio (Annual)0.47x
13-Week Price Return-18.30%
Total Debt / Equity (Annual)0.46x
Current Ratio (Quarterly)1.09x
Enterprise Value$7.72M
Revenue / Share Growth (5Y)-2.90%
Asset Turnover (TTM)3.36x
Book Value / Share Growth (5Y)-16.67%
Revenue / Employee (Annual)$635,500
Inventory Turnover (Annual)2.64x
Pretax Margin (Annual)-2.67%
Cash / Share (Annual)$3.25
3-Month Return Std Dev110.97%
Gross Margin (5Y Avg)76.99%
Net Income / Employee (TTM)$-74,900
EBITDA CAGR (5Y)-36.60%
EBITDA Interim CAGR (5Y)-52.36%
ROE (Last FY)28.91%
Net Interest Coverage (Annual)0.22x
EPS Basic Excl Extra (Annual)$-8.00
P/FCF (TTM)3.84x
Receivables Turnover (TTM)1899.86x
Total Debt / Equity (Quarterly)0.53x
EPS Incl Extra (TTM)$-6.71
Receivables Turnover (Annual)10803.80x
ROI (TTM)-14.98%
P/S Ratio (TTM)0.10x
Pretax Margin (5Y Avg)0.97%
Revenue / Share (Annual)$56.83
Tangible BV / Share (Annual)$4.46
Free OCF CAGR (5Y)-11.90%
Price vs S&P 500 (52W)-64.43%
Year-to-Date Return-30.91%
5-Day Price Return6.44%
EPS Normalized (Annual)$-8.00
ROA (5Y Avg)-8.39%
Net Profit Margin (Annual)-14.08%
Month-to-Date Return0.00%
Cash Flow / Share (TTM)$-2.94
EBITD / Share (Annual)$0.35
EPS Growth (3Y)-34.34%
Operating Margin (Annual)-0.39%
LT Debt / Equity (Annual)0.34x
ROI (5Y Avg)6.69%
LT Debt / Equity (Quarterly)0.42x
EPS Basic Excl Extra (TTM)$-6.71
P/TBV (Quarterly)3.01x
P/B Ratio (Annual)2.94x
Dividend / Share (TTM)$0.00
Inventory Turnover (TTM)2.45x
Pretax Margin (TTM)-0.43%
Book Value / Share (Annual)$4.57
Price vs S&P 500 (13W)-26.56%
Net Margin Growth (5Y)0.19%
Dividend Yield (TTM)0.00%
Beta0.70x
P/FCF (Annual)5.60x
Revenue / Share (TTM)$55.10
ROE (TTM)-22.75%
52-Week Low$3.80
vGradeB
gGradeD
mGradeD
vgmGradeC
Show chart for
Industry Peers — Pharmaceutical Preparations(17)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
MTEXMannatech Inc. | B | D | D | $5.70 |
| DFTXDefinium Therapeutics, Inc. Common Shares | — | — | A | $23.55 |
| CRONCronos Group Inc. Common Share | C | B | B | $2.74 |
| TLRYTilray Brands, Inc. Common Stock | B | B | D | $4.94 |
| CGCCanopy Growth Corporation Common Shares | C | D | C | $1.03 |
| USNAUSANA Health Sciences Inc | B | D | C | $18.03 |
| NAGENiagen Bioscience, Inc. Common Stock | C | B | D | $3.45 |
| SNDLSundial Growers Inc. Common Shares | A | C | C | $1.42 |
| ACBAurora Cannabis Inc. Common Shares | B | C | C | $3.38 |
| MDWDMediWound Ltd. | D | F | D | $14.18 |
| FTLFFitLife Brands, Inc. Common Stock | B | C | D | $9.87 |
About
Mannatech Inc is a wellness company that develops and sells nutritional supplements, skincare products, and weight-management solutions. The company operates across three major regions—the Americas, Europe/Middle East/Africa, and Asia/Pacific—with the Americas generating the majority of its revenue. Its product portfolio targets consumers seeking health and anti-aging benefits.